NanoBio Closes $11 Million Series C Financing Round
ANN ARBOR - NanoBio Corporation announced Wednesday it has closed an $11 million Series C financing round, including full participation from its existing investor syndicate. Proceeds from the financing will be used to advance the company?s development programs for herpes labialis (cold sores), cystic fibrosis and nanoemulsion-based vaccines for respiratory syncytial virus (RSV) and genital